Mechanistically, we found that down-regulation of BCR-ABL activities could promote efflux of intracellular IPP from CML cells, which consequently activated the expansion of γδT cells. The gene discussed is IPP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.